General Information
BounceWatch is an independent company data service, not affiliated with Bionure. To contact Bionure, visit bionure.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Bionure compare?
A PDF of Bionure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Bionure soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Bionure on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Spain Market
Biotechnology
About Bionure
Business keywords: biotech, neurodegenerative diseases, clinical stage, drug development, neuroprotection, remyelination, orphan designation, ophthalmology, rare diseases, SGK agonists, optic neuritis, neuromyelitis optica, multiple sclerosis, neuro-inflammation, clinical trials
Funding Rounds & Investors (3)
View AllBionure Alternatives & Competitors
View All AlternativesR&D pharma dedicated to developing innovative medicines to treat patients suffering from Central ner...
BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenera...
Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Diseases usi...
FAQ About Bionure
Source: BounceWatch company record for Bionure, https://bouncewatch.com/company/bionure, updated 31 December 2024. When citing, please name BounceWatch and link this page.